Abstract
It has been known for over 50 years that the amount of nuclear chromatin (DNA) in malignant neoplasms differs from that of homologous normal cells (1). More recently, it has been shown that nuclear DNA content correlates with the clinical outcome of various human neoplasms including urologic malignancies (2–10). An important problem in the care of patients with renal cell carcinoma (RCC) is the prediction of the neoplasms malignant potential, and in turn the patient’s prognosis. Various parameters have been used to assess the malignant potential of renal cell carcinoma, including clinical and pathologic stage, histologic grade, tumor size, nuclear morphology, immunohistochemistry, age, elevated erythrocyte sedimentation rate, and hypercalcemia. To date, the most important predictors of prognosis in patients with RCC have been tumor pathologic stage, histologic grade and type (11,12). However, it has been shown that patients within a specified stage and grade may differ in their disease progression and survival (13,14). Furthermore, none of these variables alone or in combination has shown to provide total reliable prognostic information for the individual patient. These reasons led several groups to evaluate the prognostic value of nuclear DNA content in patients with renal cell carcinoma.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Caspersson, T. and Santesson L. (1942) Studies on protein metabolism of the cells of epithelial tumors. Acta Radiol (Suppl.)46, 1–105.
Auer, G. and Tribukait B. (1980) Comparative single cell and flow DNA analysis in aspiration biopsies from breast carcinomas. Acta Pathol. Microbiol. Immunol. Scand.[A]88, 355–358.
Nativ, O., Myers, R. P., Therneau, T. M., Farrow, G. M., and Lieber, M. M. (1996) Feulgen-stained histologic sections of prostate needle biopsy specimens: reliability of DNA static image analysis. Forum6, 313–318.
Raviv, G., Leibovich, I., Mor, Y., Nass, D., Medalia, O., Goldwasser, B., and Nativ, O. (1993) Localized renal cell carcinoma treated by radical nephrectomy: Influence of pathologic data and the importance of DNA ploidy pattern on disease outcome. Cancer72, 2207–2212.
Ellis, W.J., Bauer, K. D., Oyasu, R., and McVary, K. T. (1992) Flow cytometric analysis of small renal tumors. J. Urol.148, 1774–1777.
al-Abadi, H. and Nagel R. (1992) Transitional cell of the renal pelvis and ureter: Prognostic relevance of nuclear deoxyribonucleic acid ploidy studied by slide cytometry: 8-year survival time study. J. Urol.48, 31–37.
Stephenson, R. A. (1988) Flow cytometry in genitourinary malignancies using paraffin-embedded material. Semin. Urol.6, 46–52.
Brendler, C. B. (1988) Flow cytometric evaluation of urological malignancies. J. Urol.139, 342–343.
Ljungberg, B., Forsslund, G., Stenling, R., and Zetterberg, A. (1986) Prognostic significance of the DNA content in renal cell carcinoma. J. Urol.135, 422–426.
Baisch, H., Otto, U., and Klöppel, G. (1986) Malignancy index based on flow cytometry and histology for renal cell carcinomas and its correlation to prognosis. Cytometry7, 200–04.
Medeiros, L. J., Gelb, A. B., and Weiss, L. M. (1988) Renal cell carcinoma: prognostic significance of morphological parameters in 121 cases. Cancer61, 1639–1651.
Jonas, D., Thoma, B., Beckert, H., and Weber, W. (1985) The value of morphological prognostic criteria in the assessment of renal cell carcinoma. Urol. Int.40, 148–154.
Currin, S. M., Lee, S. E., and Walther, P. J. (1990) Flow cytometric assessment of deoxyribonucleic acid content in renal adenocarcinoma: does ploidy status enhance prognostic stratification over stage alone? J. Urol.143, 458–463.
Otto, U., Baisch, H., Huland, H., and Klöppel, G. (1984) Tumor cell dexoxyribonucleic acid content in prognosis in renal cell carcinoma. J. Urol.132, 237–239.
Grignon, D. J., El-Nagger, A., Green, L. K., Ayala, A. G., Ro, J. Y., Swanson, D. A., Troncoso, P., McLemore, D., Giacco, G. G., Guinee, V. F. (1989) DNA flow cytometry as a predictor of outcome of Stage I renal cell carcinoma. Cancer63, 1161–1165.
Ljungberg, B., Stenling, R., and Roos, G. (1985) DNA content in renal cell carcinoma with reference to tumor heterogeneity. Cancer56, 503–508.
Feulgen, R. and Rossenbeck, H. (1924) microskopisch-chemischer nachweis einer mukleinsaure vom typus der thymonukleinsure preparaten. Hoppe-seylers Z. Phys. Chem.135, 203–248.
Tolles, W. E., Horvath, W. J., and Bostrom, R. C. (1961) A study of the quantitative characteristics of the exfoliative cells from the female genital tract. Cancer14, 347–454.
Hemstreet, G. P., West, S. S., and Weems, W. L., (1983) Quantitative fluorescence measurements of AO-stained normal and malignant bladder cells. Int. J. Cancer31, 577–585.
Hedley, D. W., Friedlander, M. L., Taylor, I. W., Rugg, C. A., and Musgrove, E. A. (1983) Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J. Histochem. Cytochem.31, 1333–1335.
Vindeløv, L. L., Christensen, I. J., and Nissen, N. I. (1983) A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry3, 323–327.
Cope, C., Rowe D., Delbridge, L., Philips, J., and Friedlander, M. (1991) Comparison of image analysis and flow cytometric determination of cellular DNA content. J. Clin. Pathol.44, 147–151.
Deitch, A., Wagner, D., and Richart, R. (1968) Conditions influencing the intensity of the Feulgen reaction. J. Histochem. Cytochem.16, 371–379.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc.
About this protocol
Cite this protocol
Madeb, R., Pode, D., Nativ, O. (2001). Static and Flow Cytometry. In: Mydlo, J.H. (eds) Renal Cancer. Methods in Molecular Medicine, vol 53. Humana, Totowa, NJ. https://doi.org/10.1385/1-59259-144-2:385
Download citation
DOI: https://doi.org/10.1385/1-59259-144-2:385
Publisher Name: Humana, Totowa, NJ
Print ISBN: 978-0-89603-828-8
Online ISBN: 978-1-59259-144-2
eBook Packages: Springer Protocols